Some of these models, such as amyloid-beta (Aβ) administration [7,8,9,10,11,12,13], amyloid precursor protein (APP), and/or PS1-overexpressing transgenic models [14], simulate the pathology of AD through Aβ accumulation. The gene discussed is APP; the disease is Alzheimer disease.